Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications
How Common Is Hypercortisolism in Patients With Type 2 Diabetes? Risk Factors, Epidemiology, and Making a Diagnosis Using a Dexamethasone Suppression Test.
Journal: Diabetes, obesity & metabolism
Published: May 19, 2026
In Support of Venous Glucose as a Reference Matrix for Evaluating Continuous Glucose Monitoring Accuracy.
Journal: Journal of diabetes science and technology
Published: February 04, 2026
Control of nocturnal hypoglycemia by CGM-based AI-enabled nocturnal hypoglycemia prediction: A retrospective analysis of real-world data.
Journal: Diabetes research and clinical practice
Published: November 11, 2025
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 12, 2025
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy.
Journal: The New England journal of medicine
Published: June 23, 2025
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial.
Journal: Lancet (London, England)
Published: March 21, 2025
Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes.
Journal: Diabetes technology & therapeutics
Published: March 20, 2025
Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study.
Journal: Diabetes technology & therapeutics
Published: January 27, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.
Journal: Diabetes care
Published: December 20, 2024
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
Journal: Journal of diabetes science and technology
Published: October 06, 2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.
Journal: Diabetes research and clinical practice
Published: June 07, 2024
Last Updated: 09/26/2026